Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2009 4
2010 2
2011 3
2012 3
2013 7
2014 10
2015 4
2016 2
2017 6
2018 7
2019 8
2020 10
Text availability
Article attribute
Article type
Publication date

Search Results

60 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean zhaoping li (205 results)?
PCSK9 Inhibitors: Novel Therapeutic Strategies for Lowering LDLCholesterol.
Wang Y, Liu ZP. Wang Y, et al. Mini Rev Med Chem. 2019;19(2):165-176. doi: 10.2174/1389557518666180423111442. Mini Rev Med Chem. 2019. PMID: 29692249 Review.
Recent advances in the discovery of potent and selective HDAC6 inhibitors.
Wang XX, Wan RZ, Liu ZP. Wang XX, et al. Eur J Med Chem. 2018 Jan 1;143:1406-1418. doi: 10.1016/j.ejmech.2017.10.040. Epub 2017 Oct 16. Eur J Med Chem. 2018. PMID: 29133060 Review.
Recent Developments of C-Aryl Glucoside SGLT2 Inhibitors.
Zhang Y, Liu ZP. Zhang Y, et al. Curr Med Chem. 2016;23(8):832-49. doi: 10.2174/0929867323666160210125747. Curr Med Chem. 2016. PMID: 26861002 Review.
The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo.
Cui YJ, Ma CC, Zhang CM, Tang LQ, Liu ZP. Cui YJ, et al. Eur J Med Chem. 2020 Feb 1;187:111968. doi: 10.1016/j.ejmech.2019.111968. Epub 2019 Dec 14. Eur J Med Chem. 2020. PMID: 31865012
Overcoming the emerging drug resistance of smoothened: an overview of small-molecule SMO antagonists with antiresistance activity.
Zhang H, Sun Z, Liu Z, Song C. Zhang H, et al. Among authors: liu z. Future Med Chem. 2018 Dec;10(24):2855-2875. doi: 10.4155/fmc-2018-0200. Epub 2018 Dec 17. Future Med Chem. 2018. PMID: 30557039 Review.
Recent Research Advances in Selective Matrix Metalloproteinase-13 Inhibitors as Anti-Osteoarthritis Agents.
Xie XW, Wan RZ, Liu ZP. Xie XW, et al. ChemMedChem. 2017 Aug 8;12(15):1157-1168. doi: 10.1002/cmdc.201700349. Epub 2017 Jul 19. ChemMedChem. 2017. PMID: 28722301 Review.
Evaluation of WO2017018805: 1,3,4-oxadiazole sulfamide derivatives as selective HDAC6 inhibitors.
Liang YY, Zhang CM, Liu ZP. Liang YY, et al. Expert Opin Ther Pat. 2018 Aug;28(8):647-651. doi: 10.1080/13543776.2018.1508451. Epub 2018 Aug 7. Expert Opin Ther Pat. 2018. PMID: 30073889
Natural products as zinc-dependent histone deacetylase inhibitors.
Tan S, Liu ZP. Tan S, et al. ChemMedChem. 2015 Mar;10(3):441-50. doi: 10.1002/cmdc.201402460. Epub 2015 Jan 7. ChemMedChem. 2015. PMID: 25581683 Review.
Recent developments of 19-nor-1,25-dihydroxyvitamin D3 analogues.
Zhang CF, Wan RZ, Liu ZP. Zhang CF, et al. ChemMedChem. 2013 Aug;8(8):1249-60. doi: 10.1002/cmdc.201300160. Epub 2013 Jun 20. ChemMedChem. 2013. PMID: 23788554 Review.
Discovery of novel quinazolinone derivatives as high potent and selective PI3Kδ and PI3Kδ/γ inhibitors.
Ma CC, Zhang CM, Tang LQ, Liu ZP. Ma CC, et al. Eur J Med Chem. 2018 May 10;151:9-17. doi: 10.1016/j.ejmech.2018.03.068. Epub 2018 Mar 23. Eur J Med Chem. 2018. PMID: 29601991
60 results
Jump to page
Feedback